At A Glance
- CJC-1295 With DAC is a GHRH analogue designed to remain available longer. The DAC part allows it to bind to albumin, a common protein in the bloodstream.
- The linked placebo-controlled study reported prolonged hormone changes in healthy adults.
- The DAC group supports albumin binding and extended exposure.
What Is CJC-1295 (WITH DAC)?
CJC-1295 With DAC is a GHRH analogue designed to remain available longer. The DAC part allows it to bind to albumin, a common protein in the bloodstream.
Albumin acts as a longer-lasting carrier. The peptide still uses the GHRH receptor to prompt growth-hormone release, but its availability stretches beyond the brief signal associated with shorter GHRH fragments.
Why Is Albumin Binding Interesting?
It is a clear example of molecular design changing timing. Early placebo-controlled human work reported prolonged growth-hormone and IGF-1 changes after CJC-1295. The study helps connect the carrier strategy with an actual hormone response.
Are The With DAC And No DAC Versions Interchangeable?
They share a broad pathway, but differ in structure and exposure. The albumin-binding chemistry is central to the longer duration. Keeping With DAC in the name makes the study’s meaning much clearer than simply calling everything CJC.
A Closer Look At CJC-1295 (WITH DAC)
Here are the key observations and the context that helps explain them. The original sources are linked below if you would like to explore further.
| Study or context | What was explored | What it tells us | Useful context |
|---|---|---|---|
| Early human research | Growth hormone and IGF-1 over time | The linked placebo-controlled study reported prolonged hormone changes in healthy adults. | It measured hormone responses rather than long-term performance or healthy-aging outcomes. |
| Design | Albumin as a carrier | The DAC group supports albumin binding and extended exposure. | That feature is absent from the material commonly called CJC-1295 No DAC. |
Common Questions About CJC-1295 (WITH DAC)
What is CJC-1295 (WITH DAC)?+
CJC-1295 With DAC is a GHRH analogue designed to remain available longer. The DAC part allows it to bind to albumin, a common protein in the bloodstream.
Why is albumin binding interesting?+
It is a clear example of molecular design changing timing. Early placebo-controlled human work reported prolonged growth-hormone and IGF-1 changes after CJC-1295. The study helps connect the carrier strategy with an actual hormone response.
Are the With DAC and No DAC versions interchangeable?+
They share a broad pathway, but differ in structure and exposure. The albumin-binding chemistry is central to the longer duration. Keeping With DAC in the name makes the study’s meaning much clearer than simply calling everything CJC.
Sources
Want to go a little deeper? These links take you to the studies and official records behind the guide. Study registries describe the plan; published papers report the findings.
- Prolonged stimulation of GH and IGF-I secretion by CJC-1295 in healthy adultsPeer-reviewed publication · 2006
A placebo-controlled early study reported prolonged GH and IGF-1 changes in healthy adults after CJC-1295. It supports the albumin-binding design, but it is not evidence for routine anti-aging or performance use.
- Think twice before injecting peptides bought online: unauthorized products can seriously harm youHealth Canada · 2026
For CJC-1295 (WITH DAC) context, this official Canadian advisory explains why a research-use label does not establish authorization, safety, efficacy, or product quality for human use.
Explore CJC-1295 (WITH DAC)
Review available strengths, pricing, stock status, and product documentation.